Table 6.
Inhibitor | C (M) | PM6 (%) | PM3 (%) | AM1 (%) | RM1 (%) | MNDO (%) |
---|---|---|---|---|---|---|
AP4PT | 4 × 10−4 | 90.98 | 91.18 | 90.37 | 91.20 | 91.31 |
8 × 10−4 | 95.27 | 95.39 | 94.94 | 95.40 | 95.46 | |
12 × 10−4 | 96.80 | 96.88 | 96.57 | 96.88 | 96.92 | |
16 × 10−4 | 97.58 | 97.64 | 97.40 | 97.64 | 97.68 | |
20 × 10−4 | 98.05 | 98.10 | 97.91 | 98.11 | 98.13 | |
HP4PT | 4 × 10−4 | 91.30 | 90.40 | 91.30 | 91.11 | 91.35 |
8 × 10−4 | 95.45 | 94.96 | 95.45 | 95.34 | 95.48 | |
12 × 10−4 | 96.92 | 96.58 | 96.92 | 96.84 | 96.94 | |
16 × 10−4 | 97.67 | 97.41 | 97.67 | 97.61 | 97.68 | |
20 × 10−4 | 98.13 | 97.92 | 98.13 | 98.08 | 98.14 | |
D4PT | 4 × 10−4 | 91.28 | 90.39 | 91.28 | 91.07 | 91.32 |
8 × 10−4 | 95.44 | 94.95 | 95.44 | 95.33 | 95.47 | |
12 × 10−4 | 96.91 | 96.58 | 96.92 | 96.83 | 96.93 | |
16 × 10−4 | 97.67 | 97.41 | 97.67 | 97.61 | 97.68 | |
20 × 10−4 | 98.13 | 97.92 | 98.13 | 98.08 | 98.14 |